Yasmin and Asa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Yasmin (drospirenone; ethinyl estradiol) and Asa (aspirin). Common drug interactions include pain among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Yasmin and Asa. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

21 people who take Yasmin and Asa together, and have interactions are studied.

Yasmin and Asa drug interactions.

What are the common drug interactions of Yasmin and Asa, by gender? *:

female:

  1. Pain
  2. Injury
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Anxiety
  6. Emotional distress
  7. General physical health deterioration (weak health status)
  8. Agraphia (a loss of the ability to write or to express thoughts in writing because of a brain lesion)
  9. Alopecia (absence of hair from areas of the body)
  10. Aphasia (damage to the parts of the brain that control language)

male:

  1. Dizziness
  2. Headache (pain in head)
  3. Pain in extremity
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Balance disorder
  6. Cerebellar haemorrhage (bleeding in cerebeller)
  7. Diplopia (double vision)
  8. Drug ineffective
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Embolism arterial (blood clot that has travelled through your arteries and become stuck)

What are the common drug interactions of Yasmin and Asa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Anxiety
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Dyspnoea (difficult or laboured respiration)
  5. Emotional distress
  6. Eye haemorrhage (bleeding in the eye)
  7. Fear
  8. General physical health deterioration (weak health status)
  9. Heart rate increased
  10. Oedema peripheral (superficial swelling)

20-29:

  1. Anxiety
  2. Emotional distress
  3. General physical health deterioration (weak health status)
  4. Injury
  5. Pain
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Abdominal pain
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Blood pressure diastolic decreased
  10. Blood pressure systolic decreased

30-39:

  1. Quality of life decreased
  2. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Emotional distress
  8. General physical health deterioration (weak health status)
  9. Injury
  10. Pain

40-49:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Injury
  3. Pain
  4. Abdominal distension
  5. Abdominal pain lower
  6. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  7. Cholecystitis (infection of gallbladder)
  8. Dizziness
  9. Feeling drunk
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus)

50-59:

  1. Pain
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Gait disturbance
  5. Impaired work ability
  6. Injury
  7. Knee arthroplasty
  8. Pain in extremity
  9. Retinal artery occlusion (blockage of retinal artery)

60+:

  1. Pain
  2. Hemiparesis (weakness on one side of the body)
  3. Nausea (feeling of having an urge to vomit)
  4. Abasia (inability to walk)
  5. Arthralgia (joint pain)
  6. Communication disorder (speech and language disorder)
  7. Dysarthria (speech disorder)
  8. Hemiplegia (paralysis of one side of the body)
  9. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  10. Joint swelling

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 14.29%
  2. High Blood Pressure: 3 people, 14.29%
  3. Sleep Disorder: 2 people, 9.52%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%
  5. Premenstrual Syndrome: 2 people, 9.52%
  6. Pain: 2 people, 9.52%
  7. Depression: 2 people, 9.52%
  8. Acne (skin problems that cause pimples): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and Asa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Yasmin and Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yasmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol and aspirin (the active ingredients of Yasmin and Asa, respectively), and Yasmin and Asa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: